AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2022 Issue 3; Ask the Editor
Tumor-Infiltrating Lymphocyte Therapy
A patient was admitted for treatment of metastatic melanoma, with tumor-infiltrating lymphocyte (TIL) therapy. Autologous TIL LN-145 infusion was administered via port-a cath every twelve hours over the next several days. TIL is an antineoplastic immunotherapy, in which the patient’s lymphocytes are harvested, multiplied in a lab and then reinfused back into the patient. What is the appropriate ICD-10-PCS code assignment for the administration of TIL LN-145? ...
Subscribe or sign in to view the full article.
Article Overview
This article addresses coding for a hospital admission involving tumor-infiltrating lymphocyte (TIL) therapy for metastatic melanoma. It is aimed at coding professionals who need to understand the procedure context and the ICD-10-PCS assignment referenced in the example, along with the broader clinical and coding scenario surrounding this therapy.
Why This Topic Matters
TIL therapy is an evolving oncology treatment, and accurate inpatient procedural coding depends on understanding the therapy context and the applicable ICD-10-PCS framework. This article helps readers recognize how the procedure is represented in the inpatient code set and why the admission setting matters.
What You Will Learn
- How tumor-infiltrating lymphocyte therapy is described in an inpatient setting
- What clinical context surrounds the coding example
- How the article frames the ICD-10-PCS assignment for the procedure
- How the therapy relates to metastatic melanoma treatment
Who Should Read This
- Inpatient coders
- Coding auditors
- Health information management professionals
- Oncology billing staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com